- World rank, all time
- #35,267 of 42,892
- Rank in China
- #3,209 of 3,536
- Research works
- 293 ▼ 14% vs 2013–17
- Citations
- 2k 7.0 per fractional work
- Top-10% rate
- 28.4% record average 16.5%
- Open access
- 25% world 28%
What is Shanxi Dayi Hospital known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Health SciencesDomain | #19,693 of 20,462 | 4.8% | 194 | |
| MedicineField | #17,430 of 17,978 | 4.5% | 186 |
Each strip is that field’s whole ranked pool, with the notch where Shanxi Dayi Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.8×. Every wedge is a field page.
Which keywords describe research at Shanxi Dayi Hospital?
By fractional works in all years, weighted toward what it does more of than the world: Cancer, Inflammation, Clinical Practice Guidelines, Chemotherapy, Oxidative Stress, Prognostic Factors, Magnetic Resonance Imaging and Metastasis.
- Molecular Characterization
- Long Noncoding RNAs
- Fibrosis
- Adjuvant Therapy
- Cancer Biomarkers
- Atherosclerosis
- Neuroprotection
- Epigenetic Regulation
- Precision Medicine
- Traditional Chinese Medicine
- Biogenesis
- Endothelial Dysfunction
- Obesity
- Radiotherapy
- Metastasis
- Biomarkers
- Cardiovascular Disease
- Clinical Practice Guidelines
- Oxidative Stress
- Cancer
- Inflammation
- Epidemiology
- Chemotherapy
- Treatment
- Prognostic Factors
- Magnetic Resonance Imaging
- Diagnosis
- Immunotherapy
- Gene Expression
- Angiogenesis
- Cancer Treatment
- Surgical Management
- Regulation
- Survival Analysis
- Cardiovascular Risk
- PET Imaging
- Myocardial Infarction
- Cell Differentiation
- Neoadjuvant Chemotherapy
- RNA Regulation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation26▲ 3.8×64 topics
- Cancer26▲ 6.2×40 topics
- Epidemiology19▲ 1.58×55 topics
- Oxidative Stress16▲ 3.0×42 topics
- Chemotherapy12▲ 5.9×19 topics
- Clinical Practice Guidelines12▲ 7.2×13 topics
- Treatment12▲ 3.1×26 topics
- Cardiovascular Disease10▲ 3.0×21 topics
- Prognostic Factors10▲ 7.1×11 topics
- Biomarkers9▲ 4.8×11 topics
- Magnetic Resonance Imaging8▲ 7.8×5 topics
- Metastasis8▲ 8.3×10 topics
- Diagnosis8▲ 2.6×19 topics
- Radiotherapy8▲ 7.0×9 topics
- Immunotherapy8▲ 4.0×12 topics
- Obesity8▲ 3.5×12 topics
- Gene Expression7▲ 4.1×8 topics
- Endothelial Dysfunction7▲ 8.6×8 topics
- Angiogenesis7▲ 6.0×14 topics
- Biogenesis7▲ 21×3 topics
- Cancer Treatment7▲ 9.5×6 topics
- Traditional Chinese Medicine7▲ 15×4 topics
- Surgical Management7▲ 5.0×12 topics
- Precision Medicine6▲ 7.2×7 topics
- Regulation6▲ 3.6×11 topics
- Epigenetic Regulation6▲ 10×4 topics
- Survival Analysis6▲ 7.8×4 topics
- Neuroprotection6▲ 5.3×11 topics
- Cardiovascular Risk6▲ 5.4×7 topics
- Atherosclerosis5▲ 5.1×9 topics
- PET Imaging5▲ 8.5×4 topics
- Cancer Biomarkers5▲ 22×3 topics
- Myocardial Infarction5▲ 6.9×6 topics
- Adjuvant Therapy5▲ 15×2 topics
- Cell Differentiation5▲ 21×2 topics
- Fibrosis5▲ 8.7×7 topics
- Neoadjuvant Chemotherapy5▲ 19×2 topics
- Long Noncoding RNAs5▲ 25×1 topic
- RNA Regulation5▲ 14×1 topic
- Molecular Characterization4▲ 8.3×6 topics
Which research topics does Shanxi Dayi Hospital publish most on?
By volume in 2022–2025: Metal-Organic Frameworks: Synthesis and Applications, Educational Methods and Outcomes, Retinal Diseases and Treatments and Tissue Engineering and Regenerative Medicine.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Metal-Organic Frameworks: Synthesis and Applications Inorganic Chemistry 0 works
- 2 Educational Methods and Outcomes Education 0 works
- 3 Retinal Diseases and Treatments Ophthalmology 0 works
- 4 Tissue Engineering and Regenerative Medicine Surgery 0 works
- 5 STEM Education Education 0 works
- 6 Ziziphus Jujuba Studies and Applications Food Science 0 works
- 7 Mesenchymal stem cell research Genetics 0 works
- 8 Cancer-related molecular mechanisms research Cancer Research 0 works
- 9 Education and Character Development Education 0 works
- 10 Retinal and Macular Surgery Radiology, Nuclear Medicine and Imaging 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Shanxi Dayi Hospital's research output changed?
Output in 2018–2022 was 14% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Taiyuan
- Taiyuan University of Technology
- Shanxi University
- North University of China
- Shanxi Medical University
- Taiyuan University of Science and Technology
- Institute of Coal Chemistry
- Shanxi University of Finance and Economics
- Taiyuan Normal University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.